Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial

Published:2018-08-21 Issue:16 Volume:7 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:J Am Heart Assoc

Author:

Fanola Christina L.¹²,Ruff Christian T.²,Murphy Sabina A.²,Jin James³,Duggal Anil³,Babilonia Noe A.⁴,Sritara Piyamitr⁵,Mercuri Michele F.³,Kamphuisen Pieter W.⁶,Antman Elliott M.²,Braunwald Eugene²,Giugliano Robert P.²

Affiliation:

1. Division of Cardiology University of Minnesota Minneapolis MN

2. TIMI Study Group Cardiovascular Division Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA

3. Daiichi Sankyo Pharma Development Edison NJ

4. Philippine Heart Center Quezon City Philippines

5. Division of Cardiology Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

6. Department of Internal Medicine Tergooi Hospital Hilversum the Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. Global epidemiology of atrial fibrillation

2. Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case–control study

3. Relation Between Cancer and Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke Study)

4. Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation

5. Atrial Fibrillation as a Marker of Occult Cancer

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants;American Journal of Cardiovascular Drugs;2024-09-06

2. Use of DOACs in frail elderly patients in light of class genericization;International Journal of Cardiology;2024-09

3. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

4. Arrhythmias in oncological patients: a compact overview for the clinician;Herzschrittmachertherapie + Elektrophysiologie;2024-08-11

5. Crosslink between atrial fibrillation and cancer: a therapeutic conundrum;Cardio-Oncology;2024-08-07